Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd.
Clinical trials sponsored by Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd., explained in plain language.
-
New asthma drug aims to tame severe attacks
Disease control OngoingThis study is testing an investigational antibody drug for adults with a specific type of severe asthma. The goal is to see if adding this drug to standard care can help people breathe better and have fewer serious asthma attacks over a year. About 225 participants will receive e…
Phase: PHASE2 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New shot aims to tame severe childhood eczema
Disease control OngoingThis study is testing a new injectable medication called '611' for Chinese children and adolescents with moderate to severe atopic dermatitis (eczema). The main goals are to check the drug's safety, how it moves through the body, and whether it can reduce the severity of skin sym…
Phase: PHASE1, PHASE2 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New hope for stubborn sinus problems? drug trial targets nasal polyps
Disease control OngoingThis study is testing whether an investigational drug called 611, when added to a standard nasal spray, can better control chronic sinusitis with nasal polyps in adults. It aims to reduce polyp size, ease nasal blockage, and improve smell and quality of life for people whose cond…
Phase: PHASE3 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC